Inventor
BELEMA MAKONEN
US53 patents
⚠️ This page may combine multiple inventors who share the name “BELEMA MAKONEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
30 patentsUS7659270B2Feb 9, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO72 citations98
US7759495B2Jul 20, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO41 citations96
US7745636B2Jun 29, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO53 citations94
US7741347B2Jun 22, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO52 citations94
US7704992B2Apr 27, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO58 citations94
US8642025B2Feb 4, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations92
US7906655B2Mar 15, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO37 citations92
US8377980B2Feb 19, 2013
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO22 citations91
US9227961B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations84
US8900566B2Dec 2, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US8846023B2Sep 30, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US9326973B2May 3, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations79
US9776981B2Oct 3, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO2 citations73
US9561212B2Feb 7, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations73
US9340520B2May 17, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US9018390B2Apr 28, 2015
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US9006455B2Apr 14, 2015
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations71
US6960585B2Nov 1, 2005
Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO8 citations70
US6933294B2Aug 23, 2005
Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO10 citations70
US9421192B2Aug 23, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO1 citations63
US8383094B2Feb 26, 2013
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US7176214B2Feb 13, 2007
Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO3 citations62
US6331570B1Dec 18, 2001
Active enantiomer of RARγ-specific agonist
BRISTOL MYERS SQUIBB CO3 citations62
US7456194B2Nov 25, 2008
Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO5 citations60
US10047056B2Aug 14, 2018
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US9758487B2Sep 12, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US9717712B2Aug 1, 2017
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
BRISTOL MYERS SQUIBB CO1 citations52
US7329668B2Feb 12, 2008
Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
BRISTOL MYERS SQUIBB CO2 citations51
US10617675B2Apr 14, 2020
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US9775831B2Oct 3, 2017
Combinations comprising biphenyl derivatives for use in the treatment of HCV
BRISTOL MYERS SQUIBB CO0 citations41
BACHAND CAROL
6 patentsUS8574563B2Nov 5, 2013
Hepatitis C virus inhibitors
BACHAND CAROL18 citations92
US8303944B2Nov 6, 2012
Hepatitis C virus inhibitors
BACHAND CAROL36 citations92
US8147818B2Apr 3, 2012
Hepatitis C virus inhibitors
BACHAND CAROL22 citations92
US8492553B2Jul 23, 2013
Hepatitis C virus inhibitors
BACHAND CAROL11 citations84
US8288562B2Oct 16, 2012
Hepatitis C virus inhibitors
BACHAND CAROL9 citations84
US8093243B2Jan 10, 2012
Hepatitis C virus inhibitors
BACHAND CAROL5 citations62
VIIV HEALTHCARE UK NO 5 LTD
4 patentsUS11505543B2Nov 22, 2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD3 citations72
US10954252B1Mar 23, 2021
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD6 citations70
US11958834B2Apr 16, 2024
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations62
US10035760B2Jul 31, 2018
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations40
BENDER JOHN A
3 patentsBELEMA MAKONEN
2 patentsLOPEZ OMAR D
2 patentsSERRANO-WU MICHAEL
1 patentROMINE JEFFREY LEE
1 patentCHEN QI
1 patentShowing the top 50 of 53 patents by PatentIndex Score.